Meet Mission Bio at EHA 2026

Join us in Stockholm at Booth G3.03 to explore how single-cell multiomics is advancing precision hematology research and translational discovery.

From measurable residual disease profiling to integrated DNA + RNA analysis, Mission Bio is helping researchers uncover clinically relevant biology with single-cell resolution. Visit our booth to connect with the team, see the latest workflows and applications, and learn how Tapestri is powering new insights across hematologic malignancies.

Featured Highlights

• Customer presentations powered by Tapestri: See how leading researchers are using the Tapestri platform to drive discoveries in AML, clonal hematopoiesis, MRD, cell therapy, epigenetics, and more.
  • CD9 MARKS THE DISEASE-PROPAGATING HEMATOPOIETIC STEM CELL POPULATION IN MYELOFIBROSIS
  • RESOLVING THE TUMOR HETEROGENEITY OF CLL SUBSET #8 AT SINGLE-CELL RESOLUTION: INSIGHTS INTO CLONAL DYNAMICS AND DISTINCT SUB-CLONAL MUTATIONAL LANDSCAPES
  • INTEGRATED SINGLE-CELL PROFILING IDENTIFIES RELAPSE-ASSOCIATED CLONAL DYNAMICS AND REFINES MRD RISK STRATIFICATION IN AML
  • MUTANT CALRETICULIN-SPECIFIC MONOCLONAL ANTIBODY, INCA033989, PRODUCES CLONAL MOLECULAR RESPONSES THAT CORRELATE WITH CLINICAL RESPONSES IN PATIENTS WITH MYELOFIBROSIS
  • SINGLE-CELL JOINT PROFILING OF GENOTYPES, EPIGENOME, AND TRANSCRIPTOMES IN TET2-MUTANT CLONAL PRE-LEUKEMIC LESIONS
  • AN INTEGRATIVE APPROACH COMBINING SINGLE-CELL DNA-SEQ AND SURFACEOME REVEALS DISTINCT EVOLUTIONARY TRAJECTORIES SPECIFIC TO SOMATIC ABNORMALITIES IN GATA2 DEFICIENCY
  • ECTOPIC ACTIVATION OF FOXF1 AND FENDRR BY T(14;16)(Q32;Q24) IDENTIFIES A HIGH-RISK T-ALL/MPAL SUBTYPE.

• Explore the latest Mission Bio solutions
  • Tapestri DNA + RNA
  • Professional Assay Services
  • Targeted CpG-Methylation
  • Custom multiomic workflows
  • And more

Visit Us at Booth G3.03

Whether you're advancing translational research, clinical development, or assay innovation, our team would love to connect.